Phase II trial of bevacizumab in the treatment of recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

被引：0
|
作者：
Monk, B. J. [1 ]
Sill, M. W. [2 ]
Burger, R. A. [1 ]
Gray, H. J. [3 ]
Buekers, T. E. [4 ]
Roman, L. D. [5 ]
机构：
[1] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA
[2] SUNY Buffalo, GOG Stat & Data Ctr, Roswell Pk Canc Inst, Buffalo, NY USA
[3] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
[4] Univ Iowa, Iowa City, IA USA
[5] Univ So Calif, Womens & Childrens Hosp, Los Angeles, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2008年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
45
引用
收藏
页码：S21 / S22
页数：2
相关论文
共 50 条
  • [1] Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
    Monk, Bradley J.
    Sill, Michael W.
    Burger, Robert A.
    Gray, Heidi J.
    Buekers, Thomas E.
    Roman, Lynda D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1069 - 1074
  • [2] A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Study
    Schilder, Russell J.
    Sill, Michael W.
    Lee, Yi-Chun
    Mannel, Robert
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 929 - 933
  • [3] Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or nonsquamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    Santin, A.
    Patricia, G.
    Sill, M.
    McMeekin, D.
    Leitao, M.
    Brown, J.
    Sutton, G.
    Van Le, L.
    Boardman, C.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S18 - S18
  • [4] Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    Santin, Alessandro D.
    Sill, Michael W.
    McMeekin, D. Scott
    Leitao, Mario M., Jr.
    Brown, Jubilee
    Sutton, Gregory P.
    Van Le, Linda
    Griffin, Patricia
    Boardman, Cecelia H.
    GYNECOLOGIC ONCOLOGY, 2011, 122 (03) : 495 - 500
  • [5] Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: A phase II trial of the gynecologic oncology group
    Mannel, RS
    Blessing, JA
    Boike, G
    GYNECOLOGIC ONCOLOGY, 2000, 79 (01) : 64 - 66
  • [6] A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: A Gynecologic Oncology Group Study
    Look, KY
    Blessing, JA
    Levenback, C
    Kohler, M
    Chafe, W
    Roman, LD
    GYNECOLOGIC ONCOLOGY, 1998, 70 (03) : 334 - 338
  • [7] A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
    Steven C. Plaxe
    John A. Blessing
    George Olt
    Nader Husseinzadah
    Samuel S. Lentz
    Koen DeGeest
    Fidel A. Valea
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 151 - 154
  • [8] Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix - A gynecologic oncology group study
    Lincoln, S
    Blessing, JA
    McGehee, R
    Lentz, SS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (01): : 84 - 85
  • [9] A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
    Plaxe, SC
    Blessing, JA
    Olt, G
    Husseinzadah, N
    Lentz, SS
    DeGeest, K
    Valea, FA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) : 151 - 154
  • [10] A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix - A Gynecologic Oncology Group Study
    Look, KY
    Blessing, JA
    Nelson, BE
    Johnson, GA
    Fowler, WC
    Reid, GC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (06): : 591 - 594
12345